Cargando…

Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?

BACKGROUND: Sutureless aortic valves were introduced to facilitate minimally invasive aortic valve surgery. Since sutureless aortic valves are a feasible procedure, we evaluated if any benefits could be identified in severe high-risk patients with active infective endocarditis of the aortic valve. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Weymann, Alexander, Konertz, Johanna, Laule, Michael, Stangl, Karl, Dohmen, Pascal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472401/
https://www.ncbi.nlm.nih.gov/pubmed/28592789
http://dx.doi.org/10.12659/MSM.902785
_version_ 1783244114524897280
author Weymann, Alexander
Konertz, Johanna
Laule, Michael
Stangl, Karl
Dohmen, Pascal M.
author_facet Weymann, Alexander
Konertz, Johanna
Laule, Michael
Stangl, Karl
Dohmen, Pascal M.
author_sort Weymann, Alexander
collection PubMed
description BACKGROUND: Sutureless aortic valves were introduced to facilitate minimally invasive aortic valve surgery. Since sutureless aortic valves are a feasible procedure, we evaluated if any benefits could be identified in severe high-risk patients with active infective endocarditis of the aortic valve. MATERIAL/METHODS: Between April 2014 and April 2015, a total of 42 patients received a sutureless Perceval(®) aortic valve (Sorin Biomedica Cardio Srl, Saluggia, Italy) for different indications. Nine of these patients (median age 71 years, range 47–83 years) suffered from active infective endocarditis, including four patients with prosthetic aortic valve endocarditis. Five patients underwent prior cardiac surgery, including transcatheter aortic valve implantation (TAVI). The median EuroSCORE II was 29.5% (range 16.8–87.7%). Post-operatively, data regarding mortality, operative results, and early operative morbidity were collected. RESULTS: There were no cases of 30-day mortality. Four patients needed abscess closure with pericardium. Three patients underwent left atrial appendix closure: one left ventricular thrombectomy, one bypass grafting, and one arch replacement. Median aortic cross-clamp and cardiopulmonary bypass time was 35 minutes (range 26–88 minutes) and 52 minutes (range 40–133 minutes), respectively. The median intubation time was 14 hours (range 1–9 hours). In these high-risk patients, no postoperative morbidity was found except for one re-intubation due to extensive delirium and one re-exploration. No pacemaker implantation was needed. Echocardiographic evaluation showed no central or para-valvular regurgitation, and a median discharge mean gradient of 5.5 mm Hg (range 2.5–10.0 mm Hg). CONCLUSIONS: Sutureless aortic valve replacement in very high-risk patients suffering from active infection endocarditis seems to be an option with limited morbidity and appropriate echocardiographic results, however, further studies are needed.
format Online
Article
Text
id pubmed-5472401
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-54724012017-06-21 Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis? Weymann, Alexander Konertz, Johanna Laule, Michael Stangl, Karl Dohmen, Pascal M. Med Sci Monit Clinical Research BACKGROUND: Sutureless aortic valves were introduced to facilitate minimally invasive aortic valve surgery. Since sutureless aortic valves are a feasible procedure, we evaluated if any benefits could be identified in severe high-risk patients with active infective endocarditis of the aortic valve. MATERIAL/METHODS: Between April 2014 and April 2015, a total of 42 patients received a sutureless Perceval(®) aortic valve (Sorin Biomedica Cardio Srl, Saluggia, Italy) for different indications. Nine of these patients (median age 71 years, range 47–83 years) suffered from active infective endocarditis, including four patients with prosthetic aortic valve endocarditis. Five patients underwent prior cardiac surgery, including transcatheter aortic valve implantation (TAVI). The median EuroSCORE II was 29.5% (range 16.8–87.7%). Post-operatively, data regarding mortality, operative results, and early operative morbidity were collected. RESULTS: There were no cases of 30-day mortality. Four patients needed abscess closure with pericardium. Three patients underwent left atrial appendix closure: one left ventricular thrombectomy, one bypass grafting, and one arch replacement. Median aortic cross-clamp and cardiopulmonary bypass time was 35 minutes (range 26–88 minutes) and 52 minutes (range 40–133 minutes), respectively. The median intubation time was 14 hours (range 1–9 hours). In these high-risk patients, no postoperative morbidity was found except for one re-intubation due to extensive delirium and one re-exploration. No pacemaker implantation was needed. Echocardiographic evaluation showed no central or para-valvular regurgitation, and a median discharge mean gradient of 5.5 mm Hg (range 2.5–10.0 mm Hg). CONCLUSIONS: Sutureless aortic valve replacement in very high-risk patients suffering from active infection endocarditis seems to be an option with limited morbidity and appropriate echocardiographic results, however, further studies are needed. International Scientific Literature, Inc. 2017-06-08 /pmc/articles/PMC5472401/ /pubmed/28592789 http://dx.doi.org/10.12659/MSM.902785 Text en © Med Sci Monit, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Weymann, Alexander
Konertz, Johanna
Laule, Michael
Stangl, Karl
Dohmen, Pascal M.
Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title_full Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title_fullStr Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title_full_unstemmed Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title_short Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
title_sort are sutureless aortic valves suitable for severe high-risk patients suffering from active infective aortic valve endocarditis?
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472401/
https://www.ncbi.nlm.nih.gov/pubmed/28592789
http://dx.doi.org/10.12659/MSM.902785
work_keys_str_mv AT weymannalexander aresuturelessaorticvalvessuitableforseverehighriskpatientssufferingfromactiveinfectiveaorticvalveendocarditis
AT konertzjohanna aresuturelessaorticvalvessuitableforseverehighriskpatientssufferingfromactiveinfectiveaorticvalveendocarditis
AT laulemichael aresuturelessaorticvalvessuitableforseverehighriskpatientssufferingfromactiveinfectiveaorticvalveendocarditis
AT stanglkarl aresuturelessaorticvalvessuitableforseverehighriskpatientssufferingfromactiveinfectiveaorticvalveendocarditis
AT dohmenpascalm aresuturelessaorticvalvessuitableforseverehighriskpatientssufferingfromactiveinfectiveaorticvalveendocarditis